Photo of Anny Fenton,  PhD

Anny Fenton, PhD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute


annyt_fenton@dfci.harvard.edu

Anny Fenton, PhD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Instructor, Medicine, Harvard Medical School

HCC PROGRAM AFFILIATION

Research Abstract

As a medical sociologist, I use mixed methods to study the vital role and experiences of cancer caregivers and their impact on patients and their care. I focus on understudied caregiving populations including individuals of color, rural caregivers, and those caring at a distance. I am particularly interested in adult-children caring for a parent with advanced cancer, a vastly understudied population that constitutes half of cancer caregivers in the United States. I am presently designing the first known intervention tailored to adult-child caregivers. The intervention will target caregivers’ and patients’ communication with each other and with their social networks. Importantly, the intervention will also address urban-rural disparities among caregivers and patients by tackling issues that rural caregivers face. My long-term research goal is to understand how the communication of families facing cancer shapes their quality of life to build rigorously researched and novel, disseminable interventions to improve families’ lives.

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Fenton ATHR, Keating NL, Ornstein KA, Kent EE, Litzelman K, Rowland JH, Wright AA. Comparing adult-child and spousal caregiver burden and potential contributors. Cancer 2022; 128:2015-2024. PubMed
  • Pozzar RA, Enzinger AC, Poort H, Furey A, Donovan H, Orechia M, Thompson E, Tavormina A, Fenton ATHR, Jaung T, Braun IM, DeMarsh A, Cooley ME, Wright AA. Developing and Field Testing BOLSTER: A Nurse-Led Care Management Intervention to Support Patients and Caregivers following Hospitalization for Gynecologic Cancer-Associated Peritoneal Carcinomatosis. J Palliat Med 2022. PubMed
  • Anderson EC, Hinton AC, Lary CW, Fenton ATHR, Antov A, Edelman E, Helbig P, Reed K, Miesfeldt S, Thomas CA, Hall MJ, Roberts JS, Rueter J, Han PKJ, . Community oncologists' perceptions and utilization of large-panel genomic tumor testing. BMC Cancer 2021; 21:1273. PubMed
  • Anderson EC, DiPalazzo J, Edelman E, Helbig P, Reed K, Miesfeldt S, Thomas C, Lucas FL, Fenton ATHR, Antov A, Hall MJ, Roberts JS, Rueter J, Han PKJ. Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices. JCO Precis Oncol 2021. PubMed
  • Fenton ATHR, Orefice C, Eun TJ, Biancarelli D, Hanchate A, Drainoni ML, Perkins RB. Effect of provider recommendation style on the length of adolescent vaccine discussions. Vaccine 2021; 39:1018-1023. PubMed
  • Poort H, Fenton ATHR, Thompson E, Dinardo MM, Liu JF, Arch JJ, Wright AA. Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study. Gynecol Oncol 2021; 160:227-233. PubMed
  • Fenton AT, Anderson EC, Scharnetzki E, Reed K, Edelman E, Antov A, Rueter J, Han PKJ, . Differences in cancer patients' and clinicians' preferences for disclosure of uncertain genomic tumor testing results. Patient Educ Couns 2021; 104:3-11. PubMed
  • Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton ATHR, Adams WG, Clark JA, Drainoni ML, Hanchate A. Improving HPV Vaccination Rates: A Stepped-Wedge Randomized Trial. Pediatrics 2020. PubMed
  • Perkins RB, Banigbe B, Fenton AT, O'Grady AK, Jansen EM, Bernstein JL, Joseph NP, Eun TJ, Biancarelli DL, Drainoni ML. Effect of a multi-component intervention on providers' HPV vaccine communication. Hum Vaccin Immunother 2020; 16:2736-2743. PubMed
  • Fenton ATHR, Eun TJ, Clark JA, Perkins RB. Calling the Shots? Adolescents' Influence on Human Papillomavirus Vaccine Decision-Making During Clinical Encounters. J Adolesc Health 2020; 66:447-454. PubMed
  • Fenton AT. Abandoning Medical Authority: When Medical Professionals Confront Stigmatized Adolescent Sex and the Human Papillomavirus (HPV) Vaccine. J Health Soc Behav 2019; 60:240-256. PubMed
  • Eun TJ, Hanchate A, Fenton AT, Clark JA, Aurora MN, Drainoni ML, Perkins RB. Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt. Hum Vaccin Immunother 2019; 15:2460-2465. PubMed
  • Fenton AT, Burkhart Q, Weech-Maldonado R, Haviland AM, Dembosky JW, Shih R, Wilson-Frederick SM, Gaillot S, Elliott MN. Geographic context of black-white disparities in Medicare CAHPS patient experience measures. Health Serv Res 2019; 54 Suppl 1:275-286. PubMed
  • Fenton AT, Eun TJ, Clark JA, Perkins RB. Indicated or elective? The association of providers' words with HPV vaccine receipt. Hum Vaccin Immunother 2018; 14:2503-2509. PubMed
  • Fenton AT, Elliott MN, Schwebel DC, Berkowitz Z, Liddon NC, Tortolero SR, Cuccaro PM, Davies SL, Schuster MA. Unequal interactions: Examining the role of patient-centered care in reducing inequitable diffusion of a medical innovation, the human papillomavirus (HPV) vaccine. Soc Sci Med 2017. PubMed
Hide